Drug General Information
Drug ID
D0F8GK
Former ID
DNCL003804
Drug Name
LY2886721
Drug Type
Small molecular drug
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 2 [541610], [551857]
Company
Lilly
Structure
Download
2D MOL

3D MOL

Formula
C18H16F2N4O2S
InChI
InChI=1S/C18H16F2N4O2S/c19-11-1-4-15(22-6-11)16(25)23-12-2-3-14(20)13(5-12)18-9-26-7-10(18)8-27-17(21)24-18/h1-6,10H,7-9H2,(H2,21,24)(H,23,25)/t10-,18-/m0/s1
InChIKey
NIDRNVHMMDAAIK-YPMLDQLKSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Beta-secretase Target Info Modulator
References
Ref 541610(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6475).
Ref 551857Clinical pipeline report, company report or official report of Eli Lilly.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.